Ardelyx, Inc. (ARDX): Depreciation & Amortization
$3.06M
Year ended 2025-12-31
$3.35M
Trailing 12 months to 2026-06-30
+38.8%
3-year compound annual growth
+3.8%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.06M | +48.3% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $2.06M | +59.7% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $1.29M | +12.9% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $1.14M | -59.2% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $2.81M | +10.5% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $2.54M | n/a | 2023-03-02, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $3.06M | +48.3% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $15.01M | +26.6% |
| MannKind Corp (MNKD) | 2025-12-31 | $12.28M | +66.7% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $13.84M | -2.6% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $60.74M | +39.5% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $5.43M | -10.6% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $24.24M | +2.6% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $13.31M | +7.8% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $7.51M | +41.7% |
Compare ARDX, ZLAB, MNKD, NATR side by side · Screen every company in Pharmaceutical Preparations ↗